Japanese authors investigated the mechanism of reduced efficacy of emicizumab in an adult patient with hemophilia A and an inhibitor, whose treatment was discontinued due to repeated bleeding episodes with prolonged aPTT.
Don‘t have an account? Create new account
Authors: doc. MUDr. Zuzana Čermáková, Ph.D.
Enter the email address that you registered with. We will send you instructions on how to set a new password.
